Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$77.91 - $163.71
Next Earnings Date
Apr 30 2025
Next Earnings Date
Apr 30 2025
Last Price
Market Cap | $5.36B |
EV | $5.14B |
Shares Outstanding | 58.58M |
Beta | 0.88 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $151.62 |
P/E 2025E | - |
P/Revenue 2025E | 11.16x |
Revenue | 9.30% |
EPS | -30.90% |
Operating Cash Flow | - |
Free Cash Flow | -43.10% |
Revenue | 26.70% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 83.06% |
Net Profit Margin 2025E | -14.47% |
ROE 2025E | -7.33% |
ROCE 2024 | -23.83% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Glaukos Corporation
GKOS
Sector
Healthcare
Industry
Medical - Devices
CEO
Burns, Thomas
Employees
995
Website
www.glaukos.comIPO Date
2015-06-25
Headquarters
One Glaukos Way, Aliso Viejo, California, 92656, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved